GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.71 $7.67 Thursday, 18th Apr 2024 BPTH stock ended at $4.20. This is 29.63% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 115.45% from a day low at $3.56 to a day high of $7.67.
90 days $0.352 $7.67
52 weeks $0.320 $7.67

Historical Bio-Path Holdings prices

Date Open High Low Close Volume
2024-03-13 $5.17 $5.66 $5.00 $5.41 83 866
2024-03-12 $5.11 $7.50 $5.11 $5.61 387 913
2024-03-11 $5.51 $6.02 $5.20 $5.25 21 704
2024-03-08 $6.04 $6.04 $5.52 $5.83 27 164
2024-03-07 $6.34 $6.34 $5.92 $6.23 24 342
2024-03-06 $6.94 $6.94 $6.32 $6.44 26 663
2024-03-05 $6.32 $6.83 $6.11 $6.31 23 790
2024-03-04 $6.00 $6.58 $5.90 $6.23 12 805
2024-03-01 $6.09 $6.24 $5.95 $6.05 8 383
2024-02-29 $5.97 $6.16 $5.68 $6.08 33 392
2024-02-28 $5.07 $6.59 $4.62 $6.03 60 173
2024-02-27 $5.73 $6.00 $5.09 $5.11 18 509
2024-02-26 $5.56 $6.12 $5.55 $5.80 10 534
2024-02-23 $6.40 $7.00 $5.73 $5.85 40 707
2024-02-22 $0.412 $0.485 $0.352 $0.362 585 439
2024-02-21 $0.412 $0.492 $0.410 $0.443 1 005 173
2024-02-20 $0.435 $0.485 $0.416 $0.437 75 973
2024-02-16 $0.447 $0.481 $0.430 $0.433 24 733
2024-02-15 $0.454 $0.480 $0.430 $0.442 38 553
2024-02-14 $0.450 $0.490 $0.450 $0.454 32 319
2024-02-13 $0.434 $0.490 $0.434 $0.455 14 475
2024-02-12 $0.480 $0.480 $0.450 $0.461 39 340
2024-02-09 $0.435 $0.473 $0.411 $0.450 102 455
2024-02-08 $0.460 $0.499 $0.442 $0.450 98 201
2024-02-07 $0.465 $0.490 $0.439 $0.464 132 837
Click to get the best stock tips daily for free!

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials f... BPTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT